Transplantation of the whole liver, or a portion of the liver, has been remarkably effective in
the treatment of liver failure and liver-based inherited metabolic diseases. In spite of
spectacular technical advances, significant morbidity and mortality remains. Furthermore,
demand for transplantable livers is progressively outpacing the supply of donated cadaver
organs, resulting in longer waiting times and increased mortality for prospective transplant
recipients [1]. The expanding use of adult living donors may abate the organ shortage to …